Roflumilast: all 117 studies that test it
Page 2 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical StudyCompletedNCT01140542Phase 2
- Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled FormoterolCompletedNCT00940329Phase 1
- A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque PsoriasisWithdrawnNCT00746434Phase 2
- A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)WithdrawnNCT00746382Phase 2
- Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)CompletedNCT00430729Phase 3
- Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)CompletedNCT00246935Phase 3
- Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).CompletedNCT00246922Phase 3
- Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)CompletedNCT00242320Phase 3
- Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).CompletedNCT00242307Phase 2/3
- Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)CompletedNCT00242294Phase 2/3
- Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)CompletedNCT00163527Phase 3
- Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)CompletedNCT00163475Phase 3
- The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)CompletedNCT00108823Phase 3
- OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)CompletedNCT00076089Phase 3
- The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)CompletedNCT00076076Phase 3
- Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)CompletedNCT00073177Phase 3
- Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)CompletedNCT00062582Phase 3